Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma

Por Thomas, E, Shaw, R J, Risk, J M
Publicado em 2005

Evidence for herpes simplex viral latency in the human cornea.

Por Kaye, S B, Lynas, C, Patterson, A, Risk, J M, McCarthy, K, Hart, C A
Publicado em 1991

Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.

Por Swift, A., Risk, J. M., Kingsnorth, A. N., Wright, T. A., Myskow, M., Field, J. K.
Publicado em 1995

The epigenetic landscape of oral squamous cell carcinoma

Por Jithesh, P V, Risk, J M, Schache, A G, Dhanda, J, Lane, B, Liloglou, T, Shaw, R J
Publicado em 2013

Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

Por Shaw, R J, Liloglou, T, Rogers, S N, Brown, J S, Vaughan, E D, Lowe, D, Field, J K, Risk, J M
Publicado em 2006

SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma

Por Dhanda, J, Triantafyllou, A, Liloglou, T, Kalirai, H, Lloyd, B, Hanlon, R, Shaw, R J, Sibson, D R, Risk, J M
Publicado no Br J Cancer (2014)

Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma

Por Schache, A G, Hall, G, Woolgar, J A, Nikolaidis, G, Triantafyllou, A, Lowe, D, Risk, J M, Shaw, R J, Liloglou, T
Publicado em 2010

Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.

Por Field, J. K., Kiaris, H., Risk, J. M., Tsiriyotis, C., Adamson, R., Zoumpourlis, V., Rowley, H., Taylor, K., Whittaker, J., Howard, P.
Publicado em 1995

Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.

Por Field, J. K., Neville, E. M., Stewart, M. P., Swift, A., Liloglou, T., Risk, J. M., Ross, H., Gosney, J. R., Donnelly, R. J.
Publicado em 1996

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma

Por Schache, A G, Liloglou, T, Risk, J M, Jones, T M, Ma, X-J, Wang, H, Bui, S, Luo, Y, Sloan, P, Shaw, R J, Robinson, M
Publicado em 2013

Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans.

Por Barnes, R M, Duguid, J K, Roberts, F M, Risk, J M, Johnson, P M, Finn, R, Hardy, J, Napier, J A, Clarke, C A
Publicado em 1987

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer

Por Shaw, R J, Omar, M M, Rokadiya, S, Kogera, F A, Lowe, D, Hall, G L, Woolgar, J A, Homer, J, Liloglou, T, Field, J K, Risk, J M
Publicado em 2009

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer

Por Yao, S, Ireland, S J, Bee, A, Beesley, C, Forootan, S S, Dodson, A, Dickinson, T, Gerard, P, Lian, L-Y, Risk, J M, Smith, P, Malki, M I, Ke, Y, Cooper, C S, Gosden, C, Foster, C S
Publicado em 2012